The United Kingdom has launched a clinical trial that helps assess the efficacy of a third 'booster' dose of seven different COVID-19 vaccines on patients' immune responses.
Fluvoxamine: An OCD Drug can Prevent Covid-19 Patients from Hospitalization
Fluvoxamine has been proven among one such drug that could be used to treat COVID-19. Dozens of COVID patients showed no clinical deterioration in their symptoms when treated with a drug, fluvoxamine.
Fluvoxamine has been proven among one such drug that could be used to treat COVID-19. Dozens of COVID patients showed no clinical deterioration in their symptoms when treated with a drug, fluvoxamine.
‘The new clinical trial launched by UK will assess COVID-19 vaccines of Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, Novavax, Valneva, Janssen and Curevac.’
It costs 19.3 million pound and is being funded by the UK government and led by the University Hospital Southampton NHS Foundation Trust, the report said. "It could be that some age groups may not need a booster and others do," Professor Saul Faust, chief investigator for the trial, from the University of Southampton, was quoted as saying.
"We are not trying to say one is better than the other.
Test your Knowledge on Coronavirus (COVID-19)
Coronavirus is a large positive-strand RNA virus that is surrounded by a protein envelope. The virus obtains its name from the S protein spikes on its surface, which resemble a crown. The overall pattern of increasing coronavirus cases is shown to spike up with the “second wave” of COVID-19.
With spiking effects of the second wave of coronavirus, the best way to keep it at bay is to follow COVID-appropriate safety practices like wearing a mask, regularly cleaning your hands, and coughing into a bent elbow or tissue along with physical distancing (6 feet about 2 arm's length), that may help evade the severity of COVID-19 infection.
Coronavirus is a large positive-strand RNA virus that is surrounded by a protein envelope. The virus obtains its name from the S protein spikes on its surface, which resemble a crown. The overall pattern of increasing coronavirus cases is shown to spike up with the “second wave” of COVID-19.
With spiking effects of the second wave of coronavirus, the best way to keep it at bay is to follow COVID-appropriate safety practices like wearing a mask, regularly cleaning your hands, and coughing into a bent elbow or tissue along with physical distancing (6 feet about 2 arm's length), that may help evade the severity of COVID-19 infection.
Advertisement
New Drug Ready for Development To Treat Cytokine Storm in COVID-19
IcanoMAB is focusing on the development of new antibodies for the treatment of cancer, immune-system related diseases and COVID-19 in closed collaboration with Charles Dinarello.
IcanoMAB is focusing on the development of new antibodies for the treatment of cancer, immune-system related diseases and COVID-19 in closed collaboration with Charles Dinarello.
The vaccines will be trialled at 18 sites across the UK, and half doses will also be tested.
Advertisement
The �Black Fungus� Hurting COVID-19 Patients
Mucormycosis often termed black fungus is now recurring among the Covid-19 patients due to the unhygienic way of delivering oxygen to patients with the indiscriminate use of steroids can be fatal.
Mucormycosis often termed black fungus is now recurring among the Covid-19 patients due to the unhygienic way of delivering oxygen to patients with the indiscriminate use of steroids can be fatal.
The participants will be asked to keep diaries of any side-effects after a third dose, and their immune responses will be tested after one, three and 12 months.
This involves testing their blood for antibodies to Coronavirus -- high levels are a sign that the body's defences are primed to fight off the virus.
There will also be a control group, who will be given a dummy vaccine. The researchers aim to release the initial trial data in in September.
Source-IANS
